To investigate the correlation of EN2 expression with clinical significance in gliomas, we performed Kaplan–Meier survival analysis and found that gliomas with higher EN2 expression carried a significantly better prognosis than those with lower EN2 expression (Fig. 1d). The gene discussed is EN2; the disease is glioma.